Enanta Pharmaceuticals (ENTA) Net Income towards Common Stockholders Growth (3y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -10.84% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 26.38% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -46.86% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 13.80% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 34.98% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -3.84% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 47.10% |
| 10 | Enanta Pharmaceuticals | 367.22 Mn | 203.44 Mn | - | 29.69% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.69% |
| Dec 31, 2025 | 25.60% |
| Sep 30, 2025 | 10.80% |
| Jun 30, 2025 | 16.80% |
| Mar 31, 2025 | 12.32% |
| Dec 31, 2024 | 9.54% |
| Sep 30, 2024 | 29.56% |
| Jun 30, 2024 | 1.93% |
| Mar 31, 2024 | 4.93% |
| Dec 31, 2023 | -58.89% |
| Sep 30, 2023 | 1.42% |
| Jun 30, 2023 | -39.91% |
| Mar 31, 2023 | -84.41% |
| Dec 31, 2022 | -60.78% |
| Sep 30, 2022 | -69.46% |
| Jun 30, 2022 | -86.68% |
| Mar 31, 2022 | -116.19% |
| Dec 31, 2021 | -46.71% |
| Sep 30, 2021 | -70.85% |
| Jun 30, 2021 | -47.12% |
| Mar 31, 2021 | -69.72% |
| Dec 31, 2020 | -39.46% |
| Sep 30, 2020 | -33.88% |
| Jun 30, 2020 | 4.99% |
| Mar 31, 2020 | 21.73% |
| Dec 31, 2019 | 54.21% |
| Sep 30, 2019 | 67.04% |
| Jun 30, 2019 | 229.66% |
| Mar 31, 2019 | 41.63% |
| Dec 31, 2018 | -17.10% |
| Sep 30, 2018 | 120.61% |
| Jun 30, 2018 | 135.06% |
| Mar 31, 2018 | -43.28% |
| Dec 31, 2017 | -50.94% |
| Sep 30, 2017 | 154.88% |
| Jun 30, 2017 | -32.62% |
| Mar 31, 2017 | -34.01% |
| Dec 31, 2016 | -14.51% |
| Sep 30, 2016 | 8.05% |
| Jun 30, 2016 | 63.09% |
| Mar 31, 2016 | 31.85% |
| Dec 31, 2015 | 190.21% |
| Sep 30, 2015 | 98.25% |
| Jun 30, 2015 | 32.45% |
| Mar 31, 2015 | 196.91% |